Status:
COMPLETED
Dermacyd Delicata Breeze - Photo Evaluation
Lead Sponsor:
Sanofi
Conditions:
Healthy
Eligibility:
FEMALE
18-60 years
Phase:
PHASE3
Brief Summary
The purpose of this study is to prove the absence of photo irritation and photo sensitivity potential of the product Dermacyd Breeze.
Eligibility Criteria
Inclusion
- Phototype Skin II and III
- Integral skin test in the region
Exclusion
- Lactation or gestation
- Use of Antiinflammatory and/or immunosuppression drugs 15 days before the selection
- Diseases which can cause immunity decrease, such as HIV, diabetes
- Use of drug photosensitizer
- History of sensitivity or irritation for topic products
- Active cutaneous disease which can change the study results
- History or photodermatosis active
- Family or personal antecedent of cutaneous photoinduced neoplasias
- Presence of a precursor lesion of cutaneous neoplasia, such as nevus melanocyte and keratoses actinium
- Intense solar exposure in the study area
- Use of new drugs or cosmetics during the study
- The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.
Key Trial Info
Start Date :
January 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
28 Patients enrolled
Trial Details
Trial ID
NCT00668486
Start Date
January 1 2008
Last Update
February 10 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sanofi-aventis administrative office
São Paulo, São Paulo, Brazil